Vale Peter Olszewski - The Legendary JJ McRoach
Federal Budget 2024 - Details, Comment & Response
2023 - Another Year In The Grass
H1, FY Reports $4m Minimum; Your RDTI is Not Revenue
Federal Election 2022 - Biotech Daily Editorial
Another Year In The Grass - With Shrooms & E
Editorial: Selective Briefings & ASX Listing Rule 15.7
Budget 2021 Special Edition; Comment & Response
A Year In The Grass - Medical Marijuana Review
Budget 2020 Special Edition; Comment & Analysis
Biotech Daily 1st Medical Marijuana Survey
CSIRO, Doherty Distance From 'Tier 1' Sars-Cov-2 Claims
Editorial: Covid-19 Spruikers, Please Stop !
Editorial: Covid-19 Coronavirus Claims
Editorial: The 2019-nCoV Coronavirus (Covid-19)
All The Dope On Medicine, Marijuana, Cannabis & Hemp
BNYM & Substantial Shareholder Notices
Federal Election 2019: Policies & Comment
Budget 2019 Comment & Analysis
Your R&D Tax Incentive Is Not Revenue
Victoria Election 2018 - Biotech Daily Editorial
Editorial: Something Is Rotten In Optiscan
2017 - The Year In Review - CEO, Chairman, Kamikaze of the Year
Biotech Daily 12th Birthday Editorial
Biotech Daily Editorial: Selective Briefings - Oct 11, 2017
Budget 2017: 1st MRFF Funding, Steady As She Goes - Biotech Daily Editorial Comment
2016 - The Year In Review: Money, Malcolm & Medical Marijuana
Ausbiotech, Biotech Daily: 'Don't Cut The 45% R&D Tax Incentive' - Sep 13, 2016
Federal Election 2016: Promises, Evidence And Credibility - Jun 30, 2016
Biotech Daily Policy On Mega-Day-Traders
NHMRC $3.3m For Windfarm Health Impacts AMA Position, Biotech Daily Comment - Mar 22, 2016
Mesoblast, The Nasdaq & Comparative Valuations - Nov 19, 2015
Biotech Daily 10th Birthday Editorial - Nov 6, 2015
PM Turnbull Puts Innovation, Chris Pyne Centre of Agenda - Comment
Benitec - Another Band Fails To Make It Big In The USA - Aug 19, 2015
Victoria State Election And State Biotechnology Policies
Biotech Daily 9th Birthday Editorial
Federal Government 'Action Plan' Comment: Cochlear, Medicines Australia, Biotech Daily, Ausbiotech
BRIL Group Senate Innovation Submission: Set Aside 25% Of $20bn MRFF For Commercialization
Biota Sacks More Staff, Closes Australian Operations - Biotech Daily Comment: A Disgrace
Federal Budget 2014 - $20b Research Fund, Details, Comment
Trials, Tribulations and Transparency - Apr 2, 2014
Federal Election 2013 Editorial: No One Offering A $1bn Phase III Trials Fund
Biotech Daily's 7th Birthday Editorial
Three Strikes For Two Strikes Board Spill Policy - Oct 16, 2012
Patrys, Citigroup And Hiding Behind Nominee Companies - Feb 15, 2012
Chemgenex, Phylogica Trading & Transparency - May 20, 2011
Disclosure & Transparency - Apr 1, 2011
The Year In Review - Dec 16, 2010
Biotech Daily 5th Birthday Editorial
Federal Election 2010 Editorial: Nepotism Our Best Hope - Aug 19, 2010
Political Changes Ring Uncertainty For Biotech - Jun 24, 2010
The Year In Review - Dec 17, 2009
4th Birthday Editorial - Nov 6, 2009
Commercialisation Australia - 'Radical Media Release, Fabulous Logo' - Oct 21, 2009
ASIC Acquires ASX Powers - Now For Transparency - Aug 24, 2009
Ausbiotech, Aspermont & Independent Journalism - Aug 5, 2009
BRIL Group Proposal For Commonwealth Commercialization Institute - July 6, 2009
ASX In Wonderland III: Corporate Regulation - June 25, 2009
Biotechs, The Law & Matters Of Principle - June 18, 2009
Fermiscan v Prof James: Who Breaks A Butterfly On A Wheel? - April 28, 2009
Why Is There Good News? - Apr 14, 2009
Once In An Economic Lifetime Opportunity - Jan 30, 2009
Genetic Technologies: Friends Of Mervyn & The Perils Of Owner-Drivers
Submission to the National Innovation Review - May 21, 2008
Budget 2008 Editorial - May 14, 2008
Opes Prime:Caveat Bloody Emptor - April 4, 2008
Conlicts of Interest and Transparency - January 19, 2007
Federal Budget 2009 Surprises Sector: Far More Than Expected